BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Singh A, Sohal A, Batta A. Recent developments in non-invasive methods for assessing metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2024; 30(39): 4324-4328 [PMID: 39492822 DOI: 10.3748/wjg.v30.i39.4324]
URL: https://www.wjgnet.com/1948-5182/full/v30/i39/4324.htm
Number Citing Articles
1
Tobias Harm, Anne-Katrin Rohlfing, Jessica Kristin Henes, Nicole Manzat, Michal Droppa, Malte Bongers, Mathias Heikenwaelder, Karin Müller, Meinrad Gawaz, Dominik Rath. Reduced Platelet Aggregation and Plasma Cytokine Levels Mitigate Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Journal of Inflammation Research 2025; : 11385 doi: 10.2147/JIR.S533707
2
Chiara Rovera, Alice Del Zoppo, Giovanni Petralli, Diego Moriconi, Chiara Rossi, Mariarosaria Distaso, Maurizia Rossana Brunetto, Ele Ferrannini, Francesco Raggi, Anna Solini. Effect of bempedoic acid on incretin axis and systemic and liver inflammation: a pilot, monocentric studyNutrition, Metabolism and Cardiovascular Diseases 2025; : 104373 doi: 10.1016/j.numecd.2025.104373
3
Supatsri Sethasine, Thananda Trakarnvanich, Witchakorn Ruamtawee, Nutachat Treerasoradaj, Paweena Susantitaphong. Association of noninvasive tests of liver fibrosis with chronic kidney disease in MASLD: a systematic review and meta-analysisScientific Reports 2025; 15(1) doi: 10.1038/s41598-025-26752-0
4
Said A. Al-Busafi, Mohammed Eslam. Liver Transplantation in the Era of Metabolic Dysfunction–Associated Fatty Liver Disease: Challenges, Ethical Dilemmas, and Future DirectionsTransplantology 2025; 6(4): 35 doi: 10.3390/transplantology6040035
5
Zhengjin Wang, Zhangxin Chen, Hanxu Zhuang. Association between urinary albumin-to-creatinine ratio and all-cause and cardiovascular-cause mortality among MASLD: NHANES 2001–2018Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1528732